Table of Contents
1. Global Economic Outlook
2. Global Market - Executive Summary
3. Global Market Overview
4. Global Market Analysis and Forecast 2018 to 2034
- 4.1. Global Market Size and Forecast By Drug Class, 2018 to 2034
- 4.1.1. Beta Lactams
- 4.1.2. Macrolides
- 4.1.3. Cephalosporins
- 4.1.4. Fluoroquinolones
- 4.1.5. Tetracycline
- 4.1.6. Other Products
- 4.2. Global Market Size and Forecast By Distribution Channel, 2018 to 2034
- 4.2.1. Hospital Pharmacies
- 4.2.2. Retail Pharmacies and Drug Stores
- 4.2.3. Online Pharmacies
- 4.3. Global Market Size and Forecast By Mode of Delivery, 2018 to 2034
- 4.3.1. Oral
- 4.3.2. Intravenous
- 4.3.3. Intramuscular
- 4.3.4. Other Mode of Delivery
5. North America Market Size and Forecast, 2018 to 2034
6. Latin America Market Size and Forecast, 2018 to 2034
7. Europe Market Size and Forecast, 2018 to 2034
8. Japan Market Size and Forecast, 2018 to 2034
9. APEJ Market Size and Forecast, 2018 to 2034
10. MEA Market Size and Forecast, 2018 to 2034
11. Global Market Company Share, Competition Landscape and Company Profiles
- 11.1. GlaxoSmithKline PLC
- 11.2. Pfizer Inc.
- 11.3. Teva Pharmaceutical Industries Limited
- 11.4. Merck KGaA
- 11.5. Sanofi
- 11.6. Abbott Laboratories Inc.
- 11.7. Novartis AG
- 11.8. Zambon Group SpA
- 11.9. BioStar Pharmaceuticals, Inc.
12. Research Methodology
13. Secondary and Primary Sources
14. Assumptions and Acronyms
15. Disclaimer
List of Tables
TABLE 01: Global Market Value (US$ Mn), 2018 to 2023
TABLE 02: Global Market Value (US$ Mn), 2024 to 2034
TABLE 03: Global Market Value (US$ Mn) and Y-o-Y, 2024 to 2034
TABLE 04: Global Beta Lactams Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 05: Global Beta Lactams Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 06: Global Beta Lactams Segment Market Share, By Region 2018 to 2023
TABLE 07: Global Beta Lactams Segment Market Share, By Region 2024 to 2034
TABLE 08: Global Beta Lactams Segment Y-o-Y, By Region 2024 to 2034
TABLE 09: Global Macrolides Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 10: Global Macrolides Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 11: Global Macrolides Segment Market Share, By Region 2018 to 2023
TABLE 12: Global Macrolides Segment Market Share, By Region 2024 to 2034
TABLE 13: Global Macrolides Segment Y-o-Y, By Region 2024 to 2034
TABLE 14: Global Cephalosporins Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 15: Global Cephalosporins Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 16: Global Cephalosporins Segment Market Share, By Region 2018 to 2023
TABLE 17: Global Cephalosporins Segment Market Share, By Region 2024 to 2034
TABLE 18: Global Cephalosporins Segment Y-o-Y, By Region 2024 to 2034
TABLE 19: Global Fluoroquinolones Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 20: Global Fluoroquinolones Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 21: Global Fluoroquinolones Segment Market Share, By Region 2018 to 2023
TABLE 22: Global Fluoroquinolones Segment Market Share, By Region 2024 to 2034
TABLE 23: Global Fluoroquinolones Segment Y-o-Y, By Region 2024 to 2034
TABLE 24: Global Tetracycline Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 25: Global Tetracycline Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 26: Global Tetracycline Segment Market Share, By Region 2018 to 2023
TABLE 27: Global Tetracycline Segment Market Share, By Region 2024 to 2034
TABLE 28: Global Tetracycline Segment Y-o-Y, By Region 2024 to 2034
TABLE 29: Global Other Products Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 30: Global Other Products Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 31: Global Other Products Segment Market Share, By Region 2018 to 2023
TABLE 32: Global Other Products Segment Market Share, By Region 2024 to 2034
TABLE 33: Global Other Products Segment Y-o-Y, By Region 2024 to 2034
TABLE 34: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 35: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 36: Global Hospital Pharmacies Segment Market Share, By Region 2018 to 2023
TABLE 37: Global Hospital Pharmacies Segment Market Share, By Region 2024 to 2034
TABLE 38: Global Hospital Pharmacies Segment Y-o-Y, By Region 2024 to 2034
TABLE 39: Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 40: Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 41: Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2018 to 2023
TABLE 42: Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2024 to 2034
TABLE 43: Global Retail Pharmacies and Drug Stores Segment Y-o-Y, By Region 2024 to 2034
TABLE 44: Global Online Pharmacies Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 45: Global Online Pharmacies Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 46: Global Online Pharmacies Segment Market Share, By Region 2018 to 2023
TABLE 47: Global Online Pharmacies Segment Market Share, By Region 2024 to 2034
TABLE 48: Global Online Pharmacies Segment Y-o-Y, By Region 2024 to 2034
TABLE 49: Global Oral Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 50: Global Oral Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 51: Global Oral Segment Market Share, By Region 2018 to 2023
TABLE 52: Global Oral Segment Market Share, By Region 2024 to 2034
TABLE 53: Global Oral Segment Y-o-Y, By Region 2024 to 2034
TABLE 54: Global Intravenous Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 55: Global Intravenous Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 56: Global Intravenous Segment Market Share, By Region 2018 to 2023
TABLE 57: Global Intravenous Segment Market Share, By Region 2024 to 2034
TABLE 58: Global Intravenous Segment Y-o-Y, By Region 2024 to 2034
TABLE 59: Global Intramuscular Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 60: Global Intramuscular Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 61: Global Intramuscular Segment Market Share, By Region 2018 to 2023
TABLE 62: Global Intramuscular Segment Market Share, By Region 2024 to 2034
TABLE 63: Global Intramuscular Segment Y-o-Y, By Region 2024 to 2034
TABLE 64: Global Other Mode of Delivery Segment Value (US$ Mn), By Region 2018 to 2023
TABLE 65: Global Other Mode of Delivery Segment Value (US$ Mn), By Region 2024 to 2034
TABLE 66: Global Other Mode of Delivery Segment Market Share, By Region 2018 to 2023
TABLE 67: Global Other Mode of Delivery Segment Market Share, By Region 2024 to 2034
TABLE 68: Global Other Mode of Delivery Segment Y-o-Y, By Region 2024 to 2034
TABLE 69: North America Current Expenditure on Health, (% of GDP), by Country, 2018 to 2023
TABLE 70: North America Per Capita Health Expenditure (US$ PPP), by Country, 2018 to 2023
TABLE 71: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2018 to 2023
TABLE 72: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2018 to 2023
TABLE 73: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2018 to 2023
TABLE 74: North America Market Value (US$ Mn), By Country 2018 to 2023
TABLE 75: North America Market Value (US$ Mn), By Country 2024 to 2034
TABLE 76: North America Market Value (US$ Mn), By Drug Class 2018 to 2023
TABLE 77: North America Market Value (US$ Mn), By Drug Class 2024 to 2034
TABLE 78: North America Market Value (US$ Mn), By Distribution Channel 2018 to 2023
TABLE 79: North America Market Value (US$ Mn), By Distribution Channel 2024 to 2034
TABLE 80: North America Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
TABLE 81: North America Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
TABLE 82: Latin America Current Expenditure on Health, (% of GDP), by Country, 2018 to 2023
TABLE 83: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2018 to 2023
TABLE 84: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2018 to 2023
TABLE 85: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2018 to 2023
TABLE 86: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2018 to 2023
TABLE 87: Latin America Market Value (US$ Mn), By Country 2018 to 2023
TABLE 88: Latin America Market Value (US$ Mn), By Country 2024 to 2034
TABLE 89: Latin America Market Value (US$ Mn), By Drug Class 2018 to 2023
TABLE 90: Latin America Market Value (US$ Mn), By Drug Class 2024 to 2034
TABLE 91: Latin America Market Value (US$ Mn), By Distribution Channel 2018 to 2023
TABLE 92: Latin America Market Value (US$ Mn), By Distribution Channel 2024 to 2034
TABLE 93: Latin America Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
TABLE 94: Latin America Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
TABLE 95: Europe Current Expenditure on Health, (% of GDP), by Country, 2018 to 2023
TABLE 96: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2018 to 2023
TABLE 97: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2018 to 2023
TABLE 98: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2018 to 2023
TABLE 99: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2018 to 2023
TABLE 100: Europe Market Value (US$ Mn), By Country 2018 to 2023
TABLE 101: Europe Market Value (US$ Mn), By Country 2024 to 2034
TABLE 102: Europe Market Value (US$ Mn), By Drug Class 2018 to 2023
TABLE 103: Europe Market Value (US$ Mn), By Drug Class 2024 to 2034
TABLE 104: Europe Market Value (US$ Mn), By Distribution Channel 2018 to 2023
TABLE 105: Europe Market Value (US$ Mn), By Distribution Channel 2024 to 2034
TABLE 106: Europe Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
TABLE 107: Europe Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
TABLE 108: Japan Current Expenditure on Health, (% of GDP), by Country, 2018 to 2023
TABLE 109: Japan Per Capita Health Expenditure (US$ PPP), by Country, 2018 to 2023
TABLE 110: Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2018 to 2023
TABLE 111: Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2018 to 2023
TABLE 112: Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2018 to 2023
TABLE 113: Japan Market Value (US$ Mn), By Country 2018 to 2023
TABLE 114: Japan Market Value (US$ Mn), By Country 2024 to 2034
TABLE 115: Japan Market Value (US$ Mn), By Drug Class 2018 to 2023
TABLE 116: Japan Market Value (US$ Mn), By Drug Class 2024 to 2034
TABLE 117: Japan Market Value (US$ Mn), By Distribution Channel 2018 to 2023
TABLE 118: Japan Market Value (US$ Mn), By Distribution Channel 2024 to 2034
TABLE 119: Japan Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
TABLE 120: Japan Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
TABLE 121: APEJ Current Expenditure on Health, (% of GDP), by Country, 2018 to 2023
TABLE 122: APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2018 to 2023
TABLE 123: APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2018 to 2023
TABLE 124: APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2018 to 2023
TABLE 125: APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2018 to 2023
TABLE 126: APEJ Market Value (US$ Mn), By Country 2018 to 2023
TABLE 127: APEJ Market Value (US$ Mn), By Country 2024 to 2034
TABLE 128: APEJ Market Value (US$ Mn), By Drug Class 2018 to 2023
TABLE 129: APEJ Market Value (US$ Mn), By Drug Class 2024 to 2034
TABLE 130: APEJ Market Value (US$ Mn), By Distribution Channel 2018 to 2023
TABLE 131: APEJ Market Value (US$ Mn), By Distribution Channel 2024 to 2034
TABLE 132: APEJ Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
TABLE 133: APEJ Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
TABLE 134: MEA Current Expenditure on Health, (% of GDP), by Country, 2018 to 2023
TABLE 135: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2018 to 2023
TABLE 136: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2018 to 2023
TABLE 137: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2018 to 2023
TABLE 138: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2018 to 2023
TABLE 139: MEA Market Value (US$ Mn), By Country 2018 to 2023
TABLE 140: MEA Market Value (US$ Mn), By Country 2024 to 2034
TABLE 141: MEA Market Value (US$ Mn), By Drug Class 2018 to 2023
TABLE 142: MEA Market Value (US$ Mn), By Drug Class 2024 to 2034
TABLE 143: MEA Market Value (US$ Mn), By Distribution Channel 2018 to 2023
TABLE 144: MEA Market Value (US$ Mn), By Distribution Channel 2024 to 2034
TABLE 145: MEA Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
TABLE 146: MEA Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
List of Figures
FIG. 01: Global Market Value (US$ Mn), 2018 to 2023
FIG. 02: Global Market Value (US$ Mn) Forecast, 2024 to 2034
FIG. 03: Global Market Value (US$ Mn) and Y-o-Y, 2024 to 2034
FIG. 04: Global Beta Lactams Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 05: Global Beta Lactams Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 06: Global Beta Lactams Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 07: Global Macrolides Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 08: Global Macrolides Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 09: Global Macrolides Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 10: Global Cephalosporins Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 11: Global Cephalosporins Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 12: Global Cephalosporins Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 13: Global Fluoroquinolones Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 14: Global Fluoroquinolones Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 15: Global Fluoroquinolones Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 16: Global Tetracycline Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 17: Global Tetracycline Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 18: Global Tetracycline Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 19: Global Other Products Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 20: Global Other Products Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 21: Global Other Products Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 22: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 23: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 24: Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 25: Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 26: Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 27: Global Retail Pharmacies and Drug Stores Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 28: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 29: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 30: Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 31: Global Oral Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 32: Global Oral Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 33: Global Oral Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 34: Global Intravenous Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 35: Global Intravenous Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 36: Global Intravenous Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 37: Global Intramuscular Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 38: Global Intramuscular Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 39: Global Intramuscular Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 40: Global Other Mode of Delivery Segment Market Value (US$ Mn) By Region, 2018 to 2023
FIG. 41: Global Other Mode of Delivery Segment Market Value (US$ Mn) By Region, 2024 to 2034
FIG. 42: Global Other Mode of Delivery Segment Y-o-Y Growth Rate, By Region, 2024 to 2034
FIG. 43: North America Market Value (US$ Mn), By Country 2018 to 2023
FIG. 44: North America Market Value (US$ Mn), By Country 2024 to 2034
FIG. 45: North America Market Value (US$ Mn), By Drug Class 2018 to 2023
FIG. 46: North America Market Value (US$ Mn), By Drug Class 2024 to 2034
FIG. 47: North America Market Value (US$ Mn), By Distribution Channel 2018 to 2023
FIG. 48: North America Market Value (US$ Mn), By Distribution Channel 2024 to 2034
FIG. 49: North America Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
FIG. 50: North America Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
FIG. 51: Latin America Market Value (US$ Mn), By Country 2018 to 2023
FIG. 52: Latin America Market Value (US$ Mn), By Country 2024 to 2034
FIG. 53: Latin America Market Value (US$ Mn), By Drug Class 2018 to 2023
FIG. 54: Latin America Market Value (US$ Mn), By Drug Class 2024 to 2034
FIG. 55: Latin America Market Value (US$ Mn), By Distribution Channel 2018 to 2023
FIG. 56: Latin America Market Value (US$ Mn), By Distribution Channel 2024 to 2034
FIG. 57: Latin America Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
FIG. 58: Latin America Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
FIG. 59: Europe Market Value (US$ Mn), By Country 2018 to 2023
FIG. 60: Europe Market Value (US$ Mn), By Country 2024 to 2034
FIG. 61: Europe Market Value (US$ Mn), By Drug Class 2018 to 2023
FIG. 62: Europe Market Value (US$ Mn), By Drug Class 2024 to 2034
FIG. 63: Europe Market Value (US$ Mn), By Distribution Channel 2018 to 2023
FIG. 64: Europe Market Value (US$ Mn), By Distribution Channel 2024 to 2034
FIG. 65: Europe Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
FIG. 66: Europe Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
FIG. 67: Japan Market Value (US$ Mn), By Country 2018 to 2023
FIG. 68: Japan Market Value (US$ Mn), By Country 2024 to 2034
FIG. 69: Japan Market Value (US$ Mn), By Drug Class 2018 to 2023
FIG. 70: Japan Market Value (US$ Mn), By Drug Class 2024 to 2034
FIG. 71: Japan Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
FIG. 72: Japan Market Value (US$ Mn), By Distribution Channel 2024 to 2034
FIG. 73: Japan Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
FIG. 74: Japan Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
FIG. 75: APEJ Market Value (US$ Mn), By Country 2018 to 2023
FIG. 76: APEJ Market Value (US$ Mn), By Country 2024 to 2034
FIG. 77: APEJ Market Value (US$ Mn), By Drug Class 2018 to 2023
FIG. 78: APEJ Market Value (US$ Mn), By Drug Class 2024 to 2034
FIG. 79: APEJ Market Value (US$ Mn), By Distribution Channel 2018 to 2023
FIG. 80: APEJ Market Value (US$ Mn), By Distribution Channel 2024 to 2034
FIG. 81: APEJ Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
FIG. 82: APEJ Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
FIG. 83: MEA Market Value (US$ Mn), By Country 2018 to 2023
FIG. 84: MEA Market Value (US$ Mn), By Country 2024 to 2034
FIG. 85: MEA Market Value (US$ Mn), By Drug Class 2018 to 2023
FIG. 86: MEA Market Value (US$ Mn), By Drug Class 2024 to 2034
FIG. 87: MEA Market Value (US$ Mn), By Distribution Channel 2018 to 2023
FIG. 88: MEA Market Value (US$ Mn), By Distribution Channel 2024 to 2034
FIG. 89: MEA Market Value (US$ Mn), By Mode of Delivery 2018 to 2023
FIG. 90: MEA Market Value (US$ Mn), By Mode of Delivery 2024 to 2034
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF